My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
mesoblast
Latest news and analysis on mesoblast
Equities
August 31, 2020 16:48
Game changing potential for loss-making Mesoblast
Melbourne-based biotech Mesoblast will achieve a world-first that could open up its drug pipeline to a massive market if it wins US Food and Drug Administration...
Glenn Freeman
Livewire Markets
August 31, 2020 16:48
September 27, 2016 14:28
A biotech that's been
misunderstood
MSB
Mesoblast Ltd
ASX:MSB
Followed by
335
people
MSB
Mesoblast Ltd
ASX:MSB
Followed by
335
people
Livewire Exclusive
Livewire Markets
September 27, 2016 14:28
September 06, 2016 06:41
Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback
Stuart Roberts
Pitt Street Research and NDF Research
September 06, 2016 06:41
Advertisement
November 24, 2013 22:52
Legislation just passed in Japan could accelerate Mesoblast's (MSB) entry into the largest market outside of the US
James Marlay
Livewire Markets
November 24, 2013 22:52
4
most
popular
Growth
7 steady ASX compounders with fundies’ tick of approval
Vishal Teckchandani,
Livewire Markets
Growth
Auscap sees a “fantastic decade” for active as it backs 6 ASX stocks poised for a snapback
Vishal Teckchandani,
Livewire Markets
Retirement
Betashares vs VanEck: The battle to build the ultimate 5-ETF super portfolio
Vishal Teckchandani,
Livewire Markets
Shares
The ASX stock UBS thinks could almost double, plus 8 more top picks
Keith Ford,
Livewire Markets
view all
Advertisement
